vaccines
245 projects
H2020Individual fellowship2015–2017Germany
AUTOOLIGO · Automated synthesis of S. pneumoniae 7F capsular polysaccharide repeating unit as candidate for conjugate vaccines
H2020Staff exchange2015–2019United Kingdom
Vaccinesurvey · Monitor population immunity against vaccine preventable diseases
7 partners · 4 countries
H2020Doctoral network2015–2018Spain
EUROLEISH-NET · Control of leishmaniasis, from bench to bedside and community
28 partners · 12 countries
H2020Doctoral network2015–2018Italy
TOLLerant · Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.
10 partners · 5 countries
FP7Individual fellowship2015–2017Netherlands
STAPHYLOMICS · Identifying host factors involved in staphylococcal infection
FP7Individual fellowship2015–2017Germany
HIV-NOPA · Assessment of functional immune responses of HIV infected individuals without protective HLA-B alleles
FP7Staff exchange2014–2018Ireland
VIP · Vaccines and Imaging Partnership
3 partners · 3 countries
FP7Individual fellowship2014–2016Italy
SAMUFLU · Self-amplifying RNA technology applied to the development of a universal influenza vaccine
FP7Individual fellowship2014–2016France
HUVASC-SEQ · Functional Genomics Analysis of Neisseria meningitidis interactions with human dermal blood vessels in vivo
FP7Individual fellowship2014–2016Italy
SV-STAPH-VAX · Structural Vaccinology to drive the design and optimization of protein antigens for a multicomponent vaccine against Staphylococcus aureus
FP7Reintegration grant2014–2017Netherlands
MEMORY CONTROL · Memory control; Molecular mechanisms underlying the scope of immunological memory
FP7Individual fellowship2014–2016France
FLU-MAL VLP · Chimeric Influenza-VLP used as vaccine platform for presentation of foreign antigens - Application to Malaria antigens
FP7Individual fellowship2014–2016Netherlands
FUNGISORT · Sorting out host recognition of fungal infection
FP7Doctoral network2014–2018Italy
DISCO · A multidisciplinary Doctoral Industrial School on novel preventive strategies against E. Coli infections
2 partners · 2 countries
FP7Reintegration grant2013–2017France
PEPTHIV · Host defence peptides from neuroendocrine cells as a new source of anti-HIV compounds
FP7Individual fellowship2013–2015Belgium
T-BAC · Exploring the roles and plasticity of T-cell responses in anti-BACterial immunity
FP7Reintegration grant2013–2017Switzerland
IRINVAC · IMMUNE RESPONSES TO INFLUENZA VACCINE
FP7Individual fellowship2013–2015Belgium
ADJSYN · Understanding how immunostimulant combinations in adjuvants synergise to enhance vaccine responses
FP7Individual fellowship2013–2015Italy
RESTAVAC · Regulation of Expression of Staphylococcus aureus Vaccine Antigen Candidates
FP7Reintegration grant2013–2017United Kingdom
MAJARVISCIG · A Single Dose, Cytomegalovirus-based Vaccine to Induce Heterosubtypic Protective Immunity to Influenza A Virus
FP7Individual fellowship2013–2015Germany
Peptide diversity · Diversity of MHC/peptide complexes in thymic compartments and their role in shaping T cell repertoire
FP7Reintegration grant2013–2017Netherlands
SIGNAL · Unravelling the immune signature of natural malaria transmission blocking immunity by protein microarray
FP7Individual fellowship2013–2015Austria
INNATEDNASENSOR · A proteomic screen to identify cytoplasmic DNA sensor proteins mediating type I Interferon production
FP7Reintegration grant2012–2016Switzerland
UBIFLU · Ubiquitin Signalling Pathways Required for Influenza Virus Replication: Biological Characterisation and Identification of Novel Drug Targets
2 partners · 2 countries